Innate Immunity in Cancer Gains Recognition with Affimed’s €1.8B Deal
Last week’s €1.75B deal between the German biotech Affimed and Swiss giant Roivant backs up…
16/11/2020 - 3 minutes
Immunotherapy
What Did European Oncology Players Offer at ASCO 2020?
Despite widespread clinical trial delays caused by the coronavirus pandemic, many oncology biotechs have been…
03/06/2020 - 10 minutes
French Startup Secures €2.3M to Advance Cancer RNA Immunotherapy
Lyon-based biopharmaceutical company Tollys has closed a Series A funding round of €2.3M to bring…
28/05/2020 - 2 minutes
iTeos Therapeutics’ Cancer Immunotherapy Boosted with €114M Funding
An oversubscribed Series B2 round has seen the biopharmaceutical company iTeos Therapeutics raise €114M, which…
02/04/2020 - 3 minutes
This Startup Hits Hidden Proteins to Make Cancer Immunotherapies
With one foot in Belgium and another in the US, Orionis Biosciences combines US and…
13/03/2020 - 4 minutes
Bicycle Therapeutics Partners Genentech in Deal Worth €1.6B
UK biotech Bicycle Therapeutics will collaborate with Genentech, now part of the Roche Group, to…
26/02/2020 - 2 minutes
Meet 20 European Immuno-Oncology Companies that are Fighting Cancer
With the success of CAR T-cell therapies and other innovative medicines in this area, immuno-oncology…
24/02/2020 - 12 minutes
Harnessing Genetic Suppression to Treat Rare Disease
Through quirks of genetics, some people are naturally resilient to heritable diseases. Thijn Brummelkamp, Managing…
05/02/2020 - 5 minutes
This Cancer Immunotherapy Attacks the Sugar Coat of Tumor Cells
The Portuguese company CellmAbs is developing cancer immunotherapies that prevent tumor cells from evading the…
31/01/2020 - 3 minutes
UK Startup Snaps up Potential Universal Cancer Immunotherapy
The cancer vaccine developer Ervaxx has licensed a preclinical-stage ‘universal’ cancer immunotherapy based on the…
27/01/2020 - 2 minutes
Off-The-Shelf Lung Cancer Vaccine Clinical Trial Gets €20M Boost
The French-Belgian company PDC*Line Pharma has raised a €20M Series B round to fund an…
22/01/2020 - 2 minutes
French Biotech Raises €19M to Hit Phase I with Cancer Immunotherapy
Alderaan Biotechnology has raised an €18.5M Series A round to push its lead cancer immunotherapy…
09/01/2020 - 2 minutes
